Business
Ozempic maker Novo Nordisk plunges 22%. What could this mean for Resmed shares?
Image source: Getty Images
When a company sheds over $100 billion of market value in one day, you sit up and pay attention, especially when that company is one of the largest companies in Europe.
Novo Nordisk (NYSE: NVO), the Danish pharmaceutical giant that launched the semaglutide sold under…
Continue Reading
-
Noosa News24 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General16 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News13 hours agoAlternative pathways to university explained
-
Noosa News19 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged